Debora Collotta, & Massimo Collino. (2016). NLRP3 Inflammasome Signaling Platform as New Pharmacological Target for Metaflammation. Diabetes Research, 3(1), e1-e3. Retrieved from https://openventio.us/index.php/DR/article/view/1635